Authors: HILGERS KF LANGENFELD MRW SCHLAICH M VEELKEN R SCHMIEDER RE

Citation: Kf. Hilgers et al., 1166-A C POLYMORPHISM OF THE ANGIOTENSIN-II TYPE-1 RECEPTOR (AT1) GENE AND THE RESPONSE TO INFUSED ANGIOTENSIN (ANG) II/, Journal of hypertension, 16, 1998, pp. 421-421

Authors: JOHN S SCHLAICH M LANGENFELD M WEIHPRECHT H SCHMITZ G WEIDINGER G SCHMIEDER RE

Citation: S. John et al., INCREASED BIOAVAILABILITY OF NITRIC-OXIDE AFTER LIPID-LOWERING THERAPY IN HYPERCHOLESTEROLEMIC PATIENTS - A RANDOMIZED, PLACEBO-CONTROLLED,DOUBLE-BLIND-STUDY, Circulation, 98(3), 1998, pp. 211-216

Authors: HILGERS KF LANGENFELD MRW SCHLAICH M VEELKEN R SCHMIEDER RE

Citation: Kf. Hilgers et al., 1166-A C POLYMORPHISM OF THE ANGIOTENSIN (ANG) II TYPE-1 RECEPTOR (AT1) AND THE RESPONSE TO INFUSED ANG-II/, Journal of the American Society of Nephrology, 8, 1997, pp. 1455-1455

Authors: SCHMIEDER RE JOHN S LANGENFELD M SCHLAICH M WEIDINGER G WEIHPRECHT H

Citation: Re. Schmieder et al., IMPROVED ENDOTHELIUM FUNCTION OF FOREARM VASCULATURE AFTER LIPID-LOWERING THERAPY, Journal of the American College of Cardiology, 29(2), 1997, pp. 7252-7252